Skip to content
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
A graphic of the flag of Australia alt
A graphic of the flag of Argentina alt
A graphic of the flag of Brazil alt
A graphic of the national flag of Canada alt
A graphic of the flag of Chile alt
A graphic of the national flag of the People's Republic of China alt
A graphic of the national flag of Colombia alt
A graphic of the national flag of Ecuador alt
A graphic of the flag of Germany alt
A graphic of the national flag of India alt
A graphic of the national flag of Japan alt
A graphic of the flag of Mexico alt
A graphic of the flag of Paraguay alt
A graphic of the flag of Peru alt
A graphic of the flag of Russia alt
Switzerland
A graphic of the flag of Switzerland alt
A graphic of the national flag of Uruguay alt
A graphic of the flag of Venezuela alt
Share
Did you like reading this message? Click the heart to show your love.
Empty Heart Icon
248
Latest News Employee Spotlight

A Message from Chairman and CEO Alex Gorsky About the Emergency Use Authorization of Johnson & Johnson's Janssen COVID-19 Vaccine

Share
Did you like reading this message? Click the heart to show your love.
Empty Heart Icon
248
The company leader shares the latest news about the U.S. Food and Drug Administration's decision about the single-shot Janssen COVID-19 vaccine.
Today's Top Reads Close

Today the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization for Johnson & Johnson’s Janssen COVID-19 vaccine—marking the culmination of a year of extraordinary innovation and collaboration by the people of Johnson & Johnson.

I know I speak on behalf of all of us when I say how proud and grateful we are for this opportunity to contribute our single-shot vaccine to the global effort to defeat COVID-19.

Just as the FDA’s decision reflects the urgency of the situation, we are moving forward without delay to ensure we can make the maximum possible impact with our vaccine.

Quote icon (top)

After much hard work and preparation, Johnson & Johnson is ready to join the fight on the ground against COVID-19 and eager to help bring this pandemic to an end—not just in the United States, but throughout the world.

Quote icon (bottom) Share
Did you like reading this message? Click the heart to show your love.
Empty Heart Icon
248

As we continue to pursue regulatory authorization around the world, our company is on track to meet our manufacturing goals, committed to making our vaccine available on a not-for-profit basis for pandemic emergency use and confident in the strength of the data from our clinical trials. Tested at the height of the pandemic, our vaccine has shown its potential to significantly reduce the burden of severe disease with just one immunization.

After much hard work and preparation, Johnson & Johnson is ready to join the fight on the ground against COVID-19 and eager to help bring this pandemic to an end—not just in the United States, but throughout the world.

Did you like reading this message? Click the heart to show your love.
Empty Heart Icon
248
Learn about the innovative ways the company is mobilizing to help combat the global outbreak caused by the novel coronavirus.

More from Johnson & Johnson

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue